Utility of measuring circulating bio-adrenomedullin and proenkephalin for 30-day mortality risk prediction in patients with covid-19 and non-covid-19 interstitial pneumonia in the emergency department

HIGHLIGHTS

• who: Ilaria Dafne Papasidero and collaborators from the Postgraduate School of Emergency Medicine, Sapienza University of Rome, Rome, Italy have published the Article: Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department, in the Journal: Medicina 2022, 1852 of 31/Oct/2022
• what: The aim of the study was to evaluate the prognostic role of two biomarkers (Bio-ADM) and proenkephalin (penKid) in patients with interstitial pneumonia (IP) at ED admission. The cut-off for . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.